These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7478575)

  • 1. An E2F-dependent late-serum-response promoter in a gene that controls glycolysis.
    Darville MI; Antoine IV; Mertens-Strijthagen JR; Dupriez VJ; Rousseau GG
    Oncogene; 1995 Oct; 11(8):1509-17. PubMed ID: 7478575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F.
    Ohtani K; Iwanaga R; Nakamura M; Ikeda M; Yabuta N; Tsuruga H; Nojima H
    Oncogene; 1999 Apr; 18(14):2299-309. PubMed ID: 10327050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.
    Geng Y; Eaton EN; Picón M; Roberts JM; Lundberg AS; Gifford A; Sardet C; Weinberg RA
    Oncogene; 1996 Mar; 12(6):1173-80. PubMed ID: 8649818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
    Bennett JD; Farlie PG; Watson RJ
    Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F-dependent mitogenic stimulation of the splicing of transcripts from an S phase-regulated gene.
    Darville MI; Rousseau GG
    Nucleic Acids Res; 1997 Jul; 25(14):2759-65. PubMed ID: 9207022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
    Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells.
    Sala A; Nicolaides NC; Engelhard A; Bellon T; Lawe DC; Arnold A; Graña X; Giordano A; Calabretta B
    Cancer Res; 1994 Mar; 54(6):1402-6. PubMed ID: 8137237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional control of the Htf9-A/RanBP-1 gene during the cell cycle.
    Di Matteo G; Fuschi P; Zerfass K; Moretti S; Ricordy R; Cenciarelli C; Tripodi M; Jansen-Durr P; Lavia P
    Cell Growth Differ; 1995 Oct; 6(10):1213-24. PubMed ID: 8845298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
    Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
    Oncogene; 1999 Sep; 18(36):5015-23. PubMed ID: 10490838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An E2F binding sequence negatively regulates the response of the insulin-like growth factor 1 (IGF-I) promoter to simian virus 40T antigen and to serum.
    Porcu P; Graña X; Li S; Swantek J; De Luca A; Giordano A; Baserga R
    Oncogene; 1994 Aug; 9(8):2125-34. PubMed ID: 8035997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
    Good L; Dimri GP; Campisi J; Chen KY
    J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcription factor E2F-1 modulates TGF-beta1 RNA expression in glial cells.
    Thatikunta P; Raj GV; Kundu M; Khalili K; Amini S
    Oncogene; 1997 Jun; 14(24):2959-69. PubMed ID: 9205103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
    Armstrong DJ; Roman A
    Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
    Mannervik M; Fan S; Ström AC; Helin K; Akusjärvi G
    Virology; 1999 Apr; 256(2):313-21. PubMed ID: 10191196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.